Half-Year 2022 Financial and Clinical Trials Update

Point of Care CER-Constant Exchange Rates CHFbn 2.8 2.4 2.0 1.6 1.2 0.8 0.4 0.0 HY 2020 HY 2021 Clinical Chem. & Immunodiagn. Coagulation & Urinalysis 2022 vs. 2021 CER growth +46% HY 2022 Hospital Glucose POC MDX +75% -8% -9% +54% Roche 191

View entire presentation